Durable complete response in a patient with BRAF-mutated advanced melanoma with ocular and skin toxicities from BRAF/MEK targeted therapy after immune checkpoint inhibitor treatment: a case report. Dermatol Reports [Internet]. 2025 Jun. 17 [cited 2025 Jun. 18];. Available from: https://journals.pagepress.org/dr/article/view/10324